aTyr Pharma to Present at Upcoming Investor Conferences

Core Insights - aTyr Pharma, Inc. is a clinical stage biotechnology company focused on developing first-in-class medicines from its proprietary tRNA synthetase platform [1][2] - The company will present at several investor conferences in May and June 2025, including the RBC Capital Markets Global Healthcare Conference and the Jefferies Global Healthcare Conference [1] Group 1: Upcoming Conferences - aTyr Pharma's President and CEO, Sanjay S. Shukla, will present at the RBC Capital Markets Global Healthcare Conference on May 21, 2025, at 11:00am EDT in New York, NY [1] - The company will also participate in the Piper Sandler 3 Annual Virtual Lung Symposium on May 27, 2025, at 2:00pm EDT [1] - Additionally, aTyr will present at the Jefferies Global Healthcare Conference on June 5, 2025, at 2:00pm EDT in New York, NY [1] Group 2: Company Overview - aTyr leverages evolutionary intelligence to develop therapies targeting fibrosis and inflammation through its tRNA synthetase biology [2] - The company's lead therapeutic candidate, efzofitimod, is a first-in-class biologic immunomodulator in clinical development for interstitial lung disease [2]